Microban (R) International Announces New Line of Antiviral Technologies | 2021-11-09 | Press Releases



North Carolina, USA – (Newsfile Corp. – Nov. 9, 2021) – Microban International, the global leader in antimicrobial solutions, odor control and sanitation / residual disinfection solutions, is pleased to announce a new range of antiviral technologies proven to reduce viral load on products and surfaces. Microban has long been a trusted partner in a wide range of sectors – from consumer and healthcare to industry and construction – and this announcement adds to the versatility of the company’s technology portfolio.

Microban® technology can be incorporated into a variety of materials during manufacturing, becoming an integral part of the product structure to provide inherent and long-lasting protection against microbes. Recent data shows that Microban’s new antiviral technologies comply with both ISO 18184 – which assesses the antiviral performance of treated textile products, such as woven and knitted fabrics, fibers, yarns and braids – and to ISO 21702, which measures activity in treated plastics and other non-porous surfaces. Extensive testing has been done to assess the effectiveness of each type of product against many viruses, including the bacteriophage Phi6, an important surrogate virus for SARS-CoV-2. The results showed that articles treated with these technologies can now benefit from a reduced viral load * by up to 99%.

Microban’s antiviral technologies inhibit the ability of viruses to remain viable on surfaces. The modes of action vary, disrupting the structure of either the outer protein envelope – to prevent viruses from recognizing or binding to host cells – or of the nucleic acid payload, to prevent viral replication. This gives manufacturers valuable product functionality and gives consumers additional peace of mind.

Michael Ruby, President of Microban International, explained: “We are delighted with the latest results confirming the antiviral activity of our new technologies. Evaluating the antiviral efficacy of products processed to a standard that conforms to the complex regulatory landscape is an arduous process, but we have always believed that our innovative solutions met rigorous ISO standards. Our world-class research team and global in-house regulatory department have worked diligently to ensure that the technology is recognized as effective and compliant in various markets, to support partners in their claims and to give clients even greater confidence. great in products protected by Microban antiviral technology. “

After the start of the COVID-19 pandemic, there has been a monumental increase in demand for antiviral technology in products, and it is easily recognized that Microban has not been the first in the industry to make claims. antivirals. Instead, the company invested significant time and resources to ensure that its antiviral technologies were not only scientifically proven to be effective in reducing viral load on surfaces and products, but that they could also be used in accordance with regulations by brands and manufacturers in a variety of territories and product types. Microban is committed to being a reliable and trusted industry leader, and its unparalleled regulatory expertise can help ensure that partners are aware of the implications that antiviral claims can have on their product types in the countries where they are. are sold.

For more information on Microban’s new line of antiviral technologies and registration requirements in your jurisdiction, visit www.microban.com/antiviral/technologies or contact your Microban representative.

* Antiviral effectiveness may vary depending on substrate type, treatment application dosage, impurities and application procedure. Only Microban antiviral technologies registered with the US EPA and compliant with EU BPRs are offered for sale. In the United States, antiviral technologies can only be incorporated into products that are or will be registered with the US EPA. Contact your Microban representative for more information.

Microban® International announces new range of antiviral technologies

To view an improved version of this graphic, please visit:


About Microban International:

Part of Barr Brands International (BBI), Microban International is home to the most trusted and well-known global brands in the antimicrobial, odor control and sanitation / disinfection markets – Microban® and Ultra-Fresh®. Our organization has enjoyed over 100 collective years of growth and revolutionized the industry. As a global leader, our proactive systems keep products cleaner and better control odors by preventing problems before they start. Microban International drives innovation by combining science and creative solutions that improve high quality consumer, textile, industrial and medical products around the world. Today, the Microban and Ultra-Fresh brands and our technologies are present on thousands of products around the world. The company is headquartered in North Carolina and does business in North America, Europe and Asia-Pacific. For more information, please visit www.microban.com.

© 2021 kdm communications limited

Editorial contact for more information or follow-up

Sarah Khan or Audrey Jestin at limited kdm communications, St Neots, United Kingdom

Phone. +44 (0) 1480 405333 Fax: +44 (0) 1480 477833

send an email to [email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/102482



About Author

Leave A Reply